Valuation: Manhattan Scientifics, Inc.

Market Cap 336K 300K 276K 251K 471K 31.79M 478K 3.33M 1.31M 16.65M 1.26M 1.23M 52.76M P/E 2022
-1.64x
P/E 2023 -1.25x
Enterprise Value 329K 293K 271K 246K 461K 31.12M 468K 3.26M 1.28M 16.31M 1.23M 1.21M 51.66M EV / Sales 2022
88,184,960x
EV / Sales 2023 -
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.01
5 years 0
Extreme 1.0E-6
0.03
10 years 0
Extreme 1.0E-6
0.05
Manager TitleAgeSince
Chief Executive Officer 74 01/11/2007
President 89 01/01/1998
Director TitleAgeSince
Chairman 89 -
Chairman 74 01/11/2007
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 559
+0.09%+1.15%+11.75%+118.26% 40.65B
-1.02%+7.30%-52.99%-32.26% 39.28B
+0.59%-0.74%-32.08%-33.70% 32.57B
+1.45%+3.48%+66.68%+167.66% 23.76B
+0.80%+3.26%-4.58%+0.35% 16.58B
-0.06%-1.20%-26.11%-27.75% 11.45B
-5.55%-3.75%+72.71%+125.51% 9.38B
-1.56%+9.93%-7.85%+72.90% 9.02B
-3.84%-11.06%-24.72%-15.80% 6.11B
Average -0.77%+1.22%+0.31%+41.69% 18.88B
Weighted average by Cap. -0.02%+2.45%-5.19%+41.59%

Financials

2022 2023
Net sales 0.05 0.04 0.04 0.04 0.07 4.74 0.07 0.5 0.2 2.48 0.19 0.18 7.86 -
Net income -2.73M -2.44M -2.25M -2.04M -3.83M -259M -3.89M -27.08M -10.67M -135M -10.25M -10.03M -429M -1.16M -1.04M -959K -872K -1.64M -110M -1.66M -11.56M -4.55M -57.82M -4.37M -4.28M -183M
Net Debt -65K -58.02K -53.53K -48.63K -91.23K -6.16M -92.63K -645K -254K -3.23M -244K -239K -10.22M -7K -6.25K -5.76K -5.24K -9.82K -663K -9.98K -69.44K -27.35K -347K -26.28K -25.71K -1.1M
Projected Income Statement - Annual - Manhattan Scientifics, Inc.
Logo Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
Employees
1
Date Price Change Volume
22/10/26 $0.000001 0.00% 375
  1. Stock Market
  2. Stocks
  3. MHTX Stock